CONSOLIDATED INDIA REVENUES AT RS 1,151 CRS
EBITDAC AT RS 166 CRS, 14.4% MARGIN
OPERATING EBITDA AT RS 98 CR, UP 52%
HOSPITAL BUSINESS REVENUES AT RS 939 CRS VS RS 910 CR
HOSPITAL BUSINESS OPERATING EBITDA AT RS 59 CRS VS RS 22 Cr; (6.3% MARGIN VS 2.4% IN Q1FY17)
DIAGNOSTIC BUSINESS REVENUES AT RS 212 CRS, UP 11%, EBITDA AT RS 39 CRS, 18.5% MARGIN
Fortis Healthcare Ltd. (Fortis), India’s leading healthcare delivery Company, today, announced its consolidated results for the quarter ended June 30, 2017 (Q1FY18).
India Business - Key Financial Highlights for the quarter (Q1FY18)
*EBITDAC refers to EBITDA before net business trust costs
Reported Group Financial Highlights for Q1FY18
Speaking on the results, Mr Bhavdeep Singh, CEO, Fortis Healthcare Ltd shared,
“Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. Our mission is to be a globally respected healthcare organization known for clinical excellence and distinctive patient care. We are striving to achieve this despite the recent challenging times faced by the healthcare sector in India. We have had an encouraging start to the year with an improvement in our financials and a healthy growth in our operating profitability. In the subsequent quarters, we believe we will witness additional gains as we reinforce our efforts and initiatives across all regions.”
The Company continued to maintain a healthy net debt to equity ratio at 0.19 times versus 0.06 times at the end of June 2016 and 0.20 times on March 31, 2017. Its net debt stood at Rs 1,216 Cr as of the quarter ended June 30, 2017
Key Highlights Q1FY18 - Hospital Business
Key Highlights Q1FY18 - Diagnostics Business
Awards & Accolades – Q1FY18
Some Cases of Clinical Excellence at Fortis – Q1FY18
For detailed Press Release - English